Equities

Clever Leaves Holdings Inc

CLVR:PKL

Clever Leaves Holdings Inc

Actions
  • Price (USD)3.50
  • Today's Change0.300 / 9.37%
  • Shares traded4.34k
  • 1 Year change-44.26%
  • Beta--
Data delayed at least 15 minutes, as of Jun 25 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Clever Leaves Holdings Inc. is a multinational operator and licensed producer of pharmaceutical-grade cannabinoids. The Company's segments include Cannabinoid and Non-Cannabinoid. The Cannabinoid segment is comprised of cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products. The Non-Cannabinoid operating segment is comprised of the brands and manufacturing assets acquired as part of its acquisition of Herbal Brands. The Non-Cannabinoid segment is engaged in the business of formulating, manufacturing, marketing, selling, distributing, and otherwise commercializing wellness products and nutraceuticals, excluding cannabinoid products. Its customers for the Herbal Brands products include specialty and health retailers, mass retailers and specialty and health stores in the United States. It offers product portfolio in two categories: nutraceuticals and cannabinoids. The nutraceutical products consist of a variety of beverage and powder products.

  • Revenue in USD (TTM)17.42m
  • Net income in USD-19.80m
  • Incorporated2020
  • Employees296.00
  • Location
    Clever Leaves Holdings IncBodega 19-B Parque Industrial Tibitoc PhTocancipa - CundinamarcaBOCA RATON 33487ColombiaCOL
  • Phone+1 6 468804382
  • Websitehttps://cleverleaves.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CERo Therapeutics Holdings Inc0.00-2.54m5.31m8.00---------0.3796-0.37960.00-0.92260.00----0.00-9.96---33.80-----------------------279.82------
CeCors Inc-100.00bn-100.00bn5.31m6.00---------------0.0163------------------------------------22.70------
Fresh Tracks Therapeutics Inc8.01m-5.69m5.32m4.00--0.5354--0.664-1.38-1.381.491.660.7326----2,001,500.00-52.10-89.76-66.50-115.24-----71.12-442.61---1,272.000.00--15.3137.6273.02------
Stemtech Corp4.64m-4.08m5.41m45.00------1.17-0.0624-0.06240.0619-0.00921.098.3565.16103,098.40-96.70------76.09---88.58--0.1045-1.812.27--------------
Synaptogenix Inc0.00-12.23m5.51m5.00--0.22-----37.38-37.380.0021.080.00----0.00-13.75-40.33-15.54-43.36------------0.00-------142.17---3.21--
Clever Leaves Holdings Inc17.42m-19.80m5.62m296.00--0.2283--0.3224-12.57-11.3811.1114.020.4181.6911.0358,841.21-47.51-23.20-58.14-26.5537.64---113.66-207.521.63-3.700.0479--6.14--47.63------
Allarity Therapeutics Inc0.00-20.94m5.62m5.00---------599.34-599.340.00-18.880.00----0.00-100.46--------------------------3.02------
Lixte Biotechnology Holdings Inc0.00-4.69m5.62m3.00---------2.38-2.380.001.390.00----0.00-118.45-104.18-130.17-111.05-----------1,253.200.00------19.41------
Processa Pharmaceuticals Inc0.00-9.83m5.63m13.00--0.6334-----6.29-6.290.003.110.00----0.00-87.82-84.35-102.32-90.03------------0.0012------59.45---34.05--
Glucose Health Inc1.11m-456.46k5.63m2.00--5.94--5.06-0.033-0.0330.08030.0561-----------86.94---153.9547.1940.68-31.99-56.93313.11--0.00--98.3924.9416.87------
HST Global Inc0.00-141.11k5.83m1.00---------0.0269-0.02690.00-0.11930.00-------29,397.92-5,836.01---------------24.24---------0.7858------
Oragenics Inc20.63k-20.26m5.85m5.00--5.66--283.44-7.98-7.980.00790.58590.0026----4,126.00-258.71-97.60-312.34-106.24-----98,214.93-36,169.75----0.0461---71.37---44.56--51.64--
Hepion Pharmaceuticals Inc0.00-38.52m5.86m22.00--1.01-----9.49-9.490.001.370.00----0.00-117.64-61.43-145.05-68.82-----------3,240.310.00-------7.92------
Intelligent Bio Solutions Inc2.83m-10.03m5.86m17.00--0.492--2.07-64.14-64.144.603.820.20412.697.77166,299.40-72.67-80.65-107.67-224.8423.33---356.09-948.541.87--0.0451--187.51367.97-28.00------
TFF Pharmaceuticals Inc885.71k-19.93m5.89m19.00--0.9024--6.65-10.20-10.200.43712.110.0647--3.7246,616.32-145.46-79.57-181.57-83.41-----2,249.83-8,687.66----0.00--48.01--33.13------
Tenax Therapeutics Inc0.00-10.10m5.91m5.00--0.4758-----24.52-24.520.006.350.00----0.00-67.96-199.16-75.66-285.64-----------105.120.0322------30.21------
Data as of Jun 25 2024. Currency figures normalised to Clever Leaves Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

2.97%Per cent of shares held by top holders
HolderShares% Held
AdvisorShares Investments LLCas of 07 Jun 202434.57k1.97%
Geode Capital Management LLCas of 30 Apr 202410.14k0.58%
Penserra Capital Management LLCas of 06 Jun 20245.29k0.30%
Tower Research Capital LLCas of 31 Mar 20241.80k0.10%
RBC Dominion Securities, Inc.as of 31 Mar 2024175.000.01%
Morgan Stanley & Co. LLCas of 31 Mar 202444.000.00%
The Nemes Rush Group LLCas of 31 Mar 202432.000.00%
Focused Wealth Management, Inc.as of 31 Mar 20240.000.00%
Osaic Wealth, Inc. (Investment Management)as of 31 Mar 20240.000.00%
The Vanguard Group, Inc.as of 31 May 20240.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.